Home Healthcare Pharmaceuticals Endometriosis Treatment Market

Endometriosis Treatment Market Size, Share & Trends Analysis Report By Drug Type (Hormonal Therapy, Non-Hormonal Therapy), By Route of Administration (Oral, Injectables, Nasal, Others (e.g., implants, transdermal patches)), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: November 26, 2025 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Endometriosis Treatment Market Size Analysis
    1. Introduction
    2. Endometriosis Treatment Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Hormonal Therapy
        1. Gonadotropin-Releasing Hormone (GnRH) Agonists
        2. Oral Contraceptives
        3. Progestins
        4. Danazol
      2. Non-Hormonal Therapy
        1. NSAIDs
        2. Analgesics
    3. Endometriosis Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Injectables
      3. Nasal
      4. Others (e.g., implants, transdermal patches)
    4. Endometriosis Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital pharmacy
      2. Retail pharmacy
      3. Others
  7. North America Endometriosis Treatment Market Size Analysis
    1. Introduction
    2. Endometriosis Treatment Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Hormonal Therapy
        1. Gonadotropin-Releasing Hormone (GnRH) Agonists
        2. Oral Contraceptives
        3. Progestins
        4. Danazol
      2. Non-Hormonal Therapy
        1. NSAIDs
        2. Analgesics
    3. Endometriosis Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Injectables
      3. Nasal
      4. Others (e.g., implants, transdermal patches)
    4. Endometriosis Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital pharmacy
      2. Retail pharmacy
      3. Others
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
  8. Europe Endometriosis Treatment Market Size Analysis
    1. Introduction
    2. Endometriosis Treatment Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Hormonal Therapy
        1. Gonadotropin-Releasing Hormone (GnRH) Agonists
        2. Oral Contraceptives
        3. Progestins
        4. Danazol
      2. Non-Hormonal Therapy
        1. NSAIDs
        2. Analgesics
    3. Endometriosis Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Injectables
      3. Nasal
      4. Others (e.g., implants, transdermal patches)
    4. Endometriosis Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital pharmacy
      2. Retail pharmacy
      3. Others
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    7. France
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
  9. APAC Endometriosis Treatment Market Size Analysis
    1. Introduction
    2. Endometriosis Treatment Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Hormonal Therapy
        1. Gonadotropin-Releasing Hormone (GnRH) Agonists
        2. Oral Contraceptives
        3. Progestins
        4. Danazol
      2. Non-Hormonal Therapy
        1. NSAIDs
        2. Analgesics
    3. Endometriosis Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Injectables
      3. Nasal
      4. Others (e.g., implants, transdermal patches)
    4. Endometriosis Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital pharmacy
      2. Retail pharmacy
      3. Others
    5. China
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    8. India
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
  10. Middle East and Africa Endometriosis Treatment Market Size Analysis
    1. Introduction
    2. Endometriosis Treatment Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Hormonal Therapy
        1. Gonadotropin-Releasing Hormone (GnRH) Agonists
        2. Oral Contraceptives
        3. Progestins
        4. Danazol
      2. Non-Hormonal Therapy
        1. NSAIDs
        2. Analgesics
    3. Endometriosis Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Injectables
      3. Nasal
      4. Others (e.g., implants, transdermal patches)
    4. Endometriosis Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital pharmacy
      2. Retail pharmacy
      3. Others
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
  11. LATAM Endometriosis Treatment Market Size Analysis
    1. Introduction
    2. Endometriosis Treatment Market Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
      1. Hormonal Therapy
        1. Gonadotropin-Releasing Hormone (GnRH) Agonists
        2. Oral Contraceptives
        3. Progestins
        4. Danazol
      2. Non-Hormonal Therapy
        1. NSAIDs
        2. Analgesics
    3. Endometriosis Treatment Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Injectables
      3. Nasal
      4. Others (e.g., implants, transdermal patches)
    4. Endometriosis Treatment Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital pharmacy
      2. Retail pharmacy
      3. Others
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Hormonal Therapy
          1. Gonadotropin-Releasing Hormone (GnRH) Agonists
          2. Oral Contraceptives
          3. Progestins
          4. Danazol
        2. Non-Hormonal Therapy
          1. NSAIDs
          2. Analgesics
      3. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Injectables
        3. Nasal
        4. Others (e.g., implants, transdermal patches)
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital pharmacy
        2. Retail pharmacy
        3. Others
  12. Competitive Landscape
    1. Endometriosis Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. AbbVie Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Bayer AG
    3. Pfizer Inc.
    4. Myovant Sciences Ltd.
    5. TerSera Therapeutics LLC
    6. ASKA Pharmaceutical Co., Ltd
    7. Takeda Pharmaceutical Company Limited
    8. Ferring
    9. Merck & Co., Inc.
    10. Gedeon Richter Plc
    11. Sanofi
    12. Teva Pharmaceutical Industries Ltd.
    13. Astellas Pharma Inc.
    14. Kissei Pharmaceutical Co., Ltd.
    15. ObsEva SA
    16. Johnson & Johnson
    17. Eli Lilly and Company
    18. Lupin Limited
    19. Sun Pharmaceutical Industries Limited
    20. Beijing Biote Pharmaceutical Co., Ltd
    21. Others
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.